Brief: Xvivo Q3 EBIT SEK 17.9 Million
Oct 23 (Reuters) - Xvivo Q3 sales SEK 189.1 million. Q3 net income SEK 4.3 million Q3 EPS SEK 0.14 Q3 adjusted EBIT SEK 17.6 million
Recent news on Xvivo Perfusion AB
See all newsSweden's XVIVO Q3 revenue beat expectations on thoracic sales
Brief: Xvivo Q3 EBIT SEK 28 Million
Brief: Xvivo Receives CE Certificates For Heart Preservation Technology
Brief: XVIVO Gets FDA Approval For Additional Patient Enrollment
Sweden's XVIVO Q2 sales beat estimates, helped by thoracic segment strength